DCBO
Docebo Inc.
DCBO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MSFT
Microsoft Corporation
MSFT has a slight edge over DCBO overall, supported by stronger modeled upside and lower modeled downside.
DCBO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
DCBO's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
DCBO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $32.48 | — |
| Cheap | 23x | $26.30 | -19% |
| Current | 28x | $32.48 | — |
| Fair | 75x | $86.97 | +168% |
| Expensive | 222x | $257 | +692% |
Historical ranges are pointers, not guarantees.
DCBO's PE is in its cheap range at 28x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over DCBO in the historical PE scenario, which offers more potential upside but is not a forecast.
DCBO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
DCBO has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
DCBO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.71 | +47% |
| Q2 2026 | $1.16 | +68% |
| Q1 2026 | $1.18 | +59% |
| Q4 2025 | $1.29 | +50% |
| Q3 2025 | $0.74 | +30% |
| Q2 2025 | $0.69 | +30% |
| Q1 2025 | $0.74 | +252% |
| Q4 2024 | $0.86 | +975% |
| Q3 2024 | $0.57 | +1040% |
DCBO has the edge over MSFT on earnings, with stronger typical year-over-year growth.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT's earnings per share have climbed steadily: $19.15 over the past year, up 36% from the year before, and higher year over year for 14 quarters in a row.
DCBO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $68.7M | +13% |
| Q1 2026 | $65.6M | +15% |
| Q4 2025 | $63M | +11% |
| Q3 2025 | $61.6M | +11% |
| Q2 2025 | $60.7M | +14% |
| Q1 2025 | $57.3M | +11% |
| Q4 2024 | $57M | +16% |
| Q3 2024 | $55.4M | +19% |
DCBO's revenue has grown year over year every quarter since late 2020: $69M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.1% | -1.3 points |
| Q1 2026 | -0.1% | -3 points |
| Q4 2025 | 15% | +1.2 points |
| Q3 2025 | 13% | +4.7 points |
| Q2 2025 | 8.4% | -0.2 points |
| Q1 2025 | 3% | -5.2 points |
| Q4 2024 | 14% | +12 points |
| Q3 2024 | 8.5% | +1.8 points |
DCBO's operating margin was 7.1% last quarter, down 1.3 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over DCBO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over DCBO on profitability, with a higher operating margin.
DCBO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.2M | -154% |
| Q1 2026 | $24M | +214% |
| Q4 2025 | $8.6M | -9.3% |
| Q3 2025 | $5.1M | +31% |
| Q2 2025 | $6M | -8% |
| Q1 2025 | $7.6M | -7% |
| Q4 2024 | $9.4M | +52% |
| Q3 2024 | $3.9M | -37% |
DCBO has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
DCBO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -1.3M shares |
| 1 year | -11% | -3.4M shares |
| 3 years | -19% | -6.4M shares |
| 5 years | -18% | -6M shares |
| Available history | -5.8% | -1.7M shares |
DCBO has the edge over MSFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $16.3M |
| Q1 2026 | $62.2M |
| Q4 2025 | $6,909 |
| Q3 2025 | $3.4M |
| Q2 2025 | $34.2M |
| Q4 2024 | $238,000 |
| Q3 2024 | $5.9M |
| Q2 2024 | $5.1M |
DCBO spent $82M buying back its own shares over the past year.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has 7.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
DCBO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | -2.6x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -2.8x | Net Cash |
| Q3 2024 | -4.2x | Net Cash |
| Q2 2024 | -4.7x | Net Cash |
DCBO's net debt is about 2.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT has the edge over DCBO on leverage, with a lower net debt burden relative to earnings.
DCBO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.1 | Overbought |
| Stochastic | 85.1 | Overbought |
DCBO's weekly RSI is 72 (overbought) and its Stochastic is 85 (overbought).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
DCBO PE vs Technology Sector
| Metric | DCBO | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | 0.3% above |
| PE % | 22 | 39 | 17 pts below |
DCBO is trading at 28x earnings, in line with the Technology sector's median of 28x.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT has the edge over DCBO on valuation relative to its sector.
DCBO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.7 | 17% above |
| 20 week MA | $24.3 | 34% above |
| 50 week MA | $21.1 | 54% above |
| 100 week MA | $26.2 | 24% above |
| 200 week MA | $34.0 | 4.5% below |
DCBO has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 4.5% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
DCBO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.1 | $57.7 | +15% |
| 2021 | $57.7 | $68.1 | +18% |
| 2022 | $68.1 | $31.9 | -53% |
| 2023 | $31.9 | $48.4 | +51% |
| 2024 | $48.4 | $45.7 | -5.6% |
| 2025 | $45.7 | $22.2 | -51% |
| 2026 YTD | $22.2 | $32.5 | +46% |
DCBO has the edge over MSFT on returns for 2026, with the stronger performance.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.